Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kaixin Jieyu Decoction is a traditional Chinese medicine (TCM) herbal formula used primarily for the treatment of depression and related mood disorders. It is composed of multiple herbs and has been shown in preclinical studies to exert antidepressant effects by modulating monoamine neurotransmitter levels—specifically serotonin (5-HT) and norepinephrine (NE)—and by regulating the expression of serotonin receptor subtypes 5-HT1A and 5-HT2A in the brain. In animal models, it normalizes behavioral changes associated with depression and restores neurochemical imbalances. The mechanism appears to involve both enhancement of monoaminergic transmission and modulation of serotonergic receptor balance[1][4][5]. The formula is rooted in TCM theory for nourishing the heart, calming the mind, strengthening the spleen, dispelling phlegm, and improving cognitive function[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Kaixin Jieyu Decoction.